XTX301XTX301-treatedmetastatic solid tumorsAdvarra Institutional Review Board
…e 2, days 2-5) from a head and neck cancer patient treated with XTX301. (A) Immunohistochemistry: CD8+ T cells (percentage of Tumor-In…
1articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: XTX301 ×
XTX301
This drug is selected. Its supporting articles are shown below.